For many health care professionals, successfully managing uncertainty means recognizing that surety is complicated and illusory and knowledge is iterative and provisional rather than definitive.
Though patient use of cannabinoids for the treatment of IBD has increased, clinical decision making on whether to formally recommend it as treatment remains difficult.
Existing patients receiving opioid analgesics and buprenorphine for opioid use disorder have continued to receive medications during the COVID-19 pandemic.
Researchers developed a framework to differentiate PD- from non-PD-related pain and classify PD-related pain into 3 groups — nociceptive, neuropathic, or nociplastic.
Investigators assessed if healthcare workers with previous SARS-CoV-2 infections mount better responses to a single dose of an mRNA vaccine than those without previous infection.
Greater education about and attention to functional neurological disorder is needed to reduce vaccine hesitancy and to make vaccination programs, like for COVID-19, more successful.
Investigators adapted a simple compartmental epidemic model to simulate SARS-CoV-2 spread, death, and associated costs in the US in an effort to understand the role of at home testing.
Researchers sought to determine the magnitude of placebo response rates and their contributing factors in clinical trials for irritable bowel syndrome.
In a clinical practice guideline issued by the American Gastroenterological Association and published in the April 1 issue of Gastroenterology, recommendations are presented relating to use of intragastric balloons (IGBs) for patients with obesity who have failed a trial of conventional weight-loss strategies.
For the first time in a decade, the U.S. Food and Drug Administration will hold a meeting to consider revoking approvals of several cancer drugs that have not been shown to extend or improve life.
